Back to Startup Insights
Fusix Biotech
Fusix Biotech is developing next-generation cancer immunotherapies.
Headquarters
Berlin, Germany
Year Founded
2022
Founders
Dr. Max Müller
Country
Germany
Financial Information
Funding Stage
Seed
Recent Funding
$580k
Funding By
BioNTech
Core Technology
Cancer immunotherapy
Product Type
Drug
Pipeline Stage (Very Important)
Preclinical
Regulatory Status
- IND Filed: No
- FDA/EMA Status: N/A
- Clinical Trial Registration: N/A
- Patents / IP Status: Filed
Partnerships
Pharma Collaborations
BioNTech
Academic / Hospital Tie-ups
Charité Berlin
CRO/CDMO Partnerships
None
Market & Differentiation
Next-gen immunotherapy